Integer Holdings Corporation
HealthcareNYSE:ITGR · New York Stock Exchange
-$1.12 today
Vol 0.14M · Avg 0.61M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$1.8B of revenue converted into $141.8M of net income for the selected period. Gross margin is 23.3% and net margin is 7.6%, showing how much revenue survives after costs and taxes. EPS is $4.01, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B +7.6% | $1.7B +10.3% | $1.6B +16.9% | $1.3B +9.0% | $1.2B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $1.4B +13.2% | $1.3B +9.7% | $1.1B +16.2% | $984.6M +11.4% | $884.1M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $425.8M -7.7% | $461.2M +12.1% | $411.5M +18.7% | $346.7M +2.9% | $337.0M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 23.1% -3.8pp | 26.9% +0.4pp | 26.5% +0.4pp | 26.0% -1.6pp | 27.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $46.3M -13.2% | $53.4M -13.8% | $62.0M +3.7% | $59.8M +15.0% | $52.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $162.6M -11.8% | $184.3M +7.5% | $171.5M +9.0% | $157.4M +11.1% | $141.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $216.5M -14.4% | $252.9M +1.9% | $248.2M +6.1% | $234.0M +16.3% | $201.3M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $126.0M +14.8% | $109.7M +13.1% | $97.0M +6.7% | $90.9M +11.4% | $81.6M | $374.2M | $1.2B | $631.8M |
| EBITDA | $293.7M -11.8% | $332.9M +20.8% | $275.7M +24.3% | $221.7M -1.3% | $224.7M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 15.9% -3.5pp | 19.4% +1.7pp | 17.7% +1.1pp | 16.7% -1.7pp | 18.4% | 5.6% | 46.3% | 42.0% |
| Operating Income | $209.3M +0.5% | $208.2M +27.5% | $163.3M +44.9% | $112.7M -17.0% | $135.7M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 11.3% -0.8pp | 12.1% +1.6pp | 10.5% +2.0pp | 8.5% -2.7pp | 11.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $42.3M -24.9% | $56.4M +5.6% | $53.4M +43.2% | $37.3M +17.8% | $31.6M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$83.9M -38.2% | -$60.7M -4.7% | -$57.9M -31.7% | -$44.0M -27.0% | -$34.6M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $125.4M -15.0% | $147.6M +40.0% | $105.4M +53.4% | $68.7M -32.0% | $101.1M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 6.8% -1.8pp | 8.6% +1.8pp | 6.8% +1.6pp | 5.2% -3.1pp | 8.3% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $22.6M -14.9% | $26.5M +63.2% | $16.2M +81.9% | $8.9M +11.0% | $8.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $102.8M -14.3% | $119.9M +32.3% | $90.7M +36.6% | $66.4M -31.4% | $96.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | 5.6% -1.4pp | 7.0% +1.2pp | 5.8% +0.8pp | 5.0% -2.9pp | 7.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $3 -17.8% | $4 +32.4% | $3 +38.1% | $2 -30.1% | $3 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $3 -15.0% | $3 +26.4% | $3 +37.2% | $2 -30.0% | $3 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $34.7M +3.4% | $33.6M +0.8% | $33.3M +0.6% | $33.1M +0.4% | $33.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $35.6M -0.2% | $35.6M +5.6% | $33.8M +1.2% | $33.4M +0.3% | $33.3M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
LivaNova PLC
NASDAQ:LIVN
$4.36B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.60B
Haemonetics Corporation
NYSE:HAE
$3.55B
Premier, Inc.
PINC
$2.34B
UFP Technologies, Inc.
NASDAQ:UFPT
$1.82B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.41B
Inspire Medical Systems, Inc.
NYSE:INSP
$1.23B
Artivion, Inc.
NYSE:AORT
$975.72M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ITGR generate?
Integer Holdings Corporation (ITGR) reported $1.85B of revenue in fiscal 2025.
Is ITGR profitable?
Integer Holdings Corporation (ITGR) reported $102.76M of net income, with a net margin of 5.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.